Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1262095

Prevalence of HEV RNA in Croatian blood donors


Gorski, Ivana; Babić, Ivana; Bingulac-Popović, Jasna; Topić-Šestan, Patricija; Jagnjić, Sandra; Jemeršić, Lorena; Prpić, Jelena; Jukić, Irena;
Prevalence of HEV RNA in Croatian blood donors // Transfusion clinique et biologique (2023) doi:10.1016/j.tracli.2023.01.005 (znanstveni, prihvaćen)


CROSBI ID: 1262095 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Prevalence of HEV RNA in Croatian blood donors

Autori
Gorski, Ivana ; Babić, Ivana ; Bingulac-Popović, Jasna ; Topić-Šestan, Patricija ; Jagnjić, Sandra ; Jemeršić, Lorena ; Prpić, Jelena ; Jukić, Irena ;

Vrsta, podvrsta
Radovi u časopisima, znanstveni

Izvornik
Transfusion clinique et biologique (2023)

Status rada
Prihvaćen

Ključne riječi
blood donors, HEV, NAT testing, transfusion-transmission, prevalence

Sažetak
Objectives. - HEV infection is asymptomatic for immunocompetent blood donors (BD). Transfused HEV- infected blood products may cause potentially hazardous HEV infection in immunocompromised patients. Evaluation of the need for routine BD HEV RNA screening primarily demands the establishment of HEV infection prevalence in Croatian BD. Materials and methods. -We tested BD samples in ID-NAT with the Procleix UltrioPlex E screening test for simultaneous detection of HBV DNA, HCV RNA, HIV-1, 2 RNA, and HEV RNA (Grifols, Spain). HEV infection was confirmed with HEV RNA quantitative test (Altona Diagnostics, Germany) and HEV IgM and HEV IgG antibody test (DIA.PRO Diagnostic Bioprobes, Italy). We analysed the HEV RNA sequence and performed a phylogenetic analysis. We recorded BD’s anamnestic data and dietary habits. BDs gave follow-up samples after two months and did not donate blood for six months. Results. - Between December 2021 and March 2022, we tested 8, 631 donations and found four HEV RNA- positive donations, which equals to one in 2, 158 donations (0.046%, 95% confidence interval, 0.018%-0.119%). Confirmatory HEV RNA testing gave results from negative to 4.73E+3 IU/ml HEV RNA. Three donations were in the serological window period. We have genotyped HEV RNA of two infected BD as genotype HEV-3c. Blood donors didn’t report any health problems and their diet included pork. Testing on follow-up samples presented seroconversion and no HEV RNA could be detected. Conclusion. - The incidence of HEV RNA infection in BD in Croatia corresponds with other European data. The decision on implementation of HEV NAT screening in Croatia needs an expert team evaluation of the possible risk of TT-HEV infection.

Izvorni jezik
Engleski

Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)



POVEZANOST RADA


Ustanove:
Hrvatski veterinarski institut, Zagreb,
Hrvatski zavod za transfuzijsku medicinu

Citiraj ovu publikaciju:

Gorski, Ivana; Babić, Ivana; Bingulac-Popović, Jasna; Topić-Šestan, Patricija; Jagnjić, Sandra; Jemeršić, Lorena; Prpić, Jelena; Jukić, Irena;
Prevalence of HEV RNA in Croatian blood donors // Transfusion clinique et biologique (2023) doi:10.1016/j.tracli.2023.01.005 (znanstveni, prihvaćen)
Gorski, I., Babić, I., Bingulac-Popović, J., Topić-Šestan, P., Jagnjić, S., Jemeršić, L., Prpić, J., Jukić, I. & (2023) Prevalence of HEV RNA in Croatian blood donors. Prihvaćen za objavljivanje u Transfusion clinique et biologique. [Preprint] doi:10.1016/j.tracli.2023.01.005.
@unknown{unknown, author = {Gorski, Ivana and Babi\'{c}, Ivana and Bingulac-Popovi\'{c}, Jasna and Topi\'{c}-\v{S}estan, Patricija and Jagnji\'{c}, Sandra and Jemer\v{s}i\'{c}, Lorena and Prpi\'{c}, Jelena and Juki\'{c}, Irena}, year = {2023}, DOI = {10.1016/j.tracli.2023.01.005}, keywords = {blood donors, HEV, NAT testing, transfusion-transmission, prevalence}, journal = {Transfusion clinique et biologique}, doi = {10.1016/j.tracli.2023.01.005}, title = {Prevalence of HEV RNA in Croatian blood donors}, keyword = {blood donors, HEV, NAT testing, transfusion-transmission, prevalence} }
@unknown{unknown, author = {Gorski, Ivana and Babi\'{c}, Ivana and Bingulac-Popovi\'{c}, Jasna and Topi\'{c}-\v{S}estan, Patricija and Jagnji\'{c}, Sandra and Jemer\v{s}i\'{c}, Lorena and Prpi\'{c}, Jelena and Juki\'{c}, Irena}, year = {2023}, DOI = {10.1016/j.tracli.2023.01.005}, keywords = {blood donors, HEV, NAT testing, transfusion-transmission, prevalence}, journal = {Transfusion clinique et biologique}, doi = {10.1016/j.tracli.2023.01.005}, title = {Prevalence of HEV RNA in Croatian blood donors}, keyword = {blood donors, HEV, NAT testing, transfusion-transmission, prevalence} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font